The importance of defined comorbities in sarcoidosis

J. Videnovic-Ivanov, V. Mihailovic-Vucinic, S. Filipovic, V. Zugic, J. Maric-Zivkovic (Belgrade, Republic Of Serbia)

Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Session: Clinical issues in diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 828

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Videnovic-Ivanov, V. Mihailovic-Vucinic, S. Filipovic, V. Zugic, J. Maric-Zivkovic (Belgrade, Republic Of Serbia). The importance of defined comorbities in sarcoidosis. Eur Respir J 2010; 36: Suppl. 54, 828

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019

Prevalence and clinical relevance of comorbidities in IPF
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

The importance of inflammatory markers in sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

The clinical symptoms of newly diagnosed sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 332s
Year: 2005

The role of obesity in patients with sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019


Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Sarcoidosis, a systemic disease
Source: Annual Congress 2005 - Sarcoidosis: update on extrathoracic organ problems
Year: 2005

Does concomitant extrapulmonary involvement changes characteristic features of pulmonary sarcoidosis?
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Severe pulmonary sarcoidosis: definition and risk stratification
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020


The features of patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 436s
Year: 2002

The autoimmune criteria of sarcoidosis
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020




Clinical manifestations of neurological involvement in sarcoidosis - in our experience
Source: Eur Respir J 2004; 24: Suppl. 48, 711s
Year: 2004

Definition and history of sarcoidosis
Source: Eur Respir Monogr 2022; 96: 1-7
Year: 2022


Atopy can determine sarcoid outcome – an Irish cohort of newly diagnosed sarcoidosis
Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Year: 2007


The frequency of etarnecept related sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017

Severe sarcoidosis: clinical features and management
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Features of tuberculosis incidence and clinical forms for sarcoidosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 202s
Year: 2004

Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 32s
Year: 2005

Pulmonary function and radiological stage in newly diagnosed sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Prevalence of ocular sarcoidosis in patients with intra thoracic sarcoidosis
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016